PUD, GERD, IBD Flashcards

1
Q

MOA of antacids

A
  1. neutralize gastric acid, raise pH >4
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

ADEs of antacids

A
  1. AlOH - constipation
  2. Mg products - diarrhea.
    combo of Al and Mg is popular
  3. Ca - tums
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

When to take antacids

A

1 hr and 3 hr after meal and at bedtime. Don’t take w/in 1-2 hr of other drugs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

MOA of H2 receptor antagonists

A
  1. inhibit all phases of gastric acid secretion

2. reduce both Volume and [H+] of gastric acid secretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Potency of H2 Receptor antagonists

A
  1. cimetidine - 1
  2. Ranitidine : 4-10
  3. Nizatidine : 4-10
  4. Famotiding : 20-50
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

ADE of Cimetidine

A
  1. inhibits CYPs thus slows metabolism of many drugs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

MOA of PPIs + how do they get to where they need to

A
  1. enteric coating allows release of pro-drug in gut, lipid solubility of PPIs permits absorption into bloodstream. PPIs then carried by blood to parietal cells and diffuse to acid pH causes protonation and trapping of drug near PP.
  2. Irreversible binding to HKATPase leads to Achlorhydria b/c all gastric acid secretion is blocked
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Details about PPIs

A
  1. omeprazole and esomeprazole - long duration of action
  2. Lansoprazole - less effective in severe esophagitis
  3. Rabeprazole - less CYP metabolism
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

MOA of Bismuth Subsalicylate (pepto bismol)

A
  1. enhance secretion of mucus and HCO3
  2. inhibit pepsin activity
  3. chelates w/ proteins at base of ulcer, forms protective barrier against acid and pepsin
  4. inhibits H plyori
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

MOA of sucralfate

A

forms sticky, viscous gel that adheres to gastric epithelial cells protecting them from acid and pepsin
- only cytoprotective agent that needs an acidic pH for max activity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

MOA of clarithromycin

A

macrolide, inhibits protein synthesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

MOA and CI of amoxcillin

A

effective against gram negative bacilli.

CI - pts allergic to penicillin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

MOA of Metronidazole

A

synthetic Abx active against obligate anaerobes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

MOA of furazolidine

A

nitrofuran antibacterial and antiprotozoal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

H Pylori Abx resistance

A
  1. Clathriomycin - 8%
  2. Metro - 43%
  3. Amoxicillin - 3%
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

MOA of metoclopramide

A

D2 receptor antagonist; w/in GIT this increases local release of ACH via 5HT4 agonism.

  1. stimulates GI SM
  2. increases amplitude of esophageal contractions
  3. accelerates gastric emptying
  4. increases LES pressure
17
Q

ADE of metoclopramide

A

Tardive dyskinesia

18
Q

MOA of sulfasalazine

A
  • 5 aminosalicylic acid derivative - acts as local anti-inflammatory agent.
  • Broke down by intestinal bacteria to sulfapyridine and 5 aminosalicylic acid.
19
Q

ADE of sulfasalazine

A

anemia, rash, and impotence

20
Q

MOA of infliximab

A

MAB against TNF-alpha

21
Q

MOa of etanercept

A

fusion protein containing ligand binding portion of TNF-alpha receptor linked to Fc portion of human IgG1.

22
Q

MOA of neomycin

A

antibacterial givens as enema to reduce bacteria in colon for portal systemic encephalopathy

23
Q

MOA of lactulose

A

semisynthetis disaccharide, fecal acidifer - retards nonionic diffusion of ammonia from colon to blood. osmotive laxative effect that discharges NH3